The INVICTUS rheumatic heart disease research program: Rationale, design and baseline characteristics of a randomized trial of rivaroxaban compared to vitamin K antagonists in rheumatic valvular disease and atrial fibrillation
Karthikeyan, G; Connolly, SJ; Ntsekhe, M; Benz, A; Rangarajan, S; Lewis, G; Yun, Y; Sharma, SK; Maldady, F; Elghamrawy, AE; Kazmi, K; Cabral, TTJ; Dayi, H; Ma, CS; Gitura, BM; Avezum, A; Zuhlke, L; Lwabi, P; Haileamlak, A; Ogah, O; Chillo, P; Paniagua, M; ElSayed, A; Dans, A; Gondwe-Chunda, L; Molefe-Baikai, OJ; Gonzalez-Hermosillo, JA; Hakim, J; Damasceno, A; Kamanzi, ER; Musuku, J; Davletov, K; Connolly, K; Mayosi, BM; Yusuf, S
Karthikeyan, G (corresponding author), All India Inst Med Sci, Dept Cardiol, New Delhi 110029, India.
AMERICAN HEART JOURNAL, 2020; 225 (): 69
